Research and Development of APIs

• 
• 
• 

The research of active pharmaceutical ingredients is carried out in compliance with the CGMP (Current Good Manufacturing Practice) standarts and specific requests of the clients.

«Grindeks» succesfully co-operates with Latvian scientific and research institutes and with foreign pharmaceutical companies. The focus is on various research projects aimed at study and development of new substances which will be used in the manufacturing of innovative and efficient medications.

Latvia is eligible country for the development of generic active pharmaceutical ingredients therefore every year portfolio of APIs is expanded with at least two new products.

Contacts

Andris Jegorovs
Director of Aсtive Pharmaceutical Ingredients business unit
e-mail: andris.jegorovs@grindeks.lv

Ēriks Ivanovskis
Aсtive Pharmaceutical Ingredients R&D Laboratory Manager
e-mails: eriks.ivanovskis@grindeks.lv